Promoting Population Health through Increased Capacity in Alcohol Epidemiology & the Prevention of Excessive Alcohol Use
Forecast
Centers for Disease Control - NCCDPHP plans to offer grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make about 12 awards worth $12.0 million in total. It is a forecast: the notice is expected around March 1, 2027, with applications due around April 30, 2027.
From the official notice on Grants.gov, last changed August 14, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards12
- Total funding$12.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | August 14, 2026 |
|---|---|
| Expected posting | March 1, 2027 |
| Expected deadline | April 30, 2027 |
| Expected award date | August 31, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
1. (Component 1 only) Applicants must be physically located and operate in the state or territory for which work is proposed. Applicants must specifically identify the state or territory in which they will work. Applicants with locations in multiple states or territories must select one state or territory, the state or territory in which that applicant is located. Applicants must provide a statement that identifies the state or territory in which the applicant will do the proposed work, evidence of operation in that state in the form of a mailing address, and must title this file "Operational Jurisdiction" and upload it as a PDF file at www.grants.gov. Applicants proposing to work in states or territories other than where the applicant is physically located and operates will be considered non-responsive and will not receive further review.2. Applicants may apply for Component 1 or Component 2, but not both. Applicants should clearly state which component they are applying for (C1 or C2) in their project title. Applicants who apply for both Component 1 and Component 2 will be considered non-responsive, and will not be entered into the review process.3. CDC will not accept and review applications with budgets greater than the ceiling of the award range ($200,000 for Component 1 and $400,000 for Component 2). Applications with budgets that exceed the ceiling of the award, which includes both direct and indirect costs, will be considered non-responsive, and will not be entered into the review process.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
CDC announces the availability of fiscal year (FY) 2027 funds to implement CDC-RFA-DP-27-0072, Promoting Population Health through Increased Capacity in Alcohol Epidemiology and the Prevention of Excessive Alcohol Use. The purpose of this NOFO is to build state capacity in alcohol epidemiology and provide the tools and information needed to perform core public health functions related to excessive alcohol use prevention in states. This increased epidemiologic capacity will help build the public health infrastructure that is needed to reduce excessive alcohol use – a leading preventable cause of death in the U.S. The NOFO includes an additional component for the delivery of expert technical assistance and training on population-level evidence-based strategies for preventing excessive alcohol use and related harms in states and communities, such as those recommended by the Community Preventive Services Task Force. The period of performance is 5 years with a 12-month budget period and an anticipated award date of 8/31/2027.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Sandi Brown, iww1@cdc.gov, 770-488-8237.
Questions people ask
Who can apply for Promoting Population Health through Increased Capacity in Alcohol Epidemiology & the Prevention of Excessive Alcohol Use?
Centers for Disease Control - NCCDPHP accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Promoting Population Health through Increased Capacity in Alcohol Epidemiology & the Prevention of Excessive Alcohol Use?
Expected deadline April 30, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
About $12.0 million in total across about 12 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience